Qingxia Hu

机构：Energy International (United States), Shandong First Medical University · ORCID：0000-0002-2508-5552

发表论文 16 篇 · 总被引 393 次 · h-index 7

代表论文

• Fluorescent probes for ferroptosis bioimaging: advances, challenges, and prospects (2023 · Chemical Society Reviews · 被引 182)
• LEM4 confers tamoxifen resistance to breast cancer cells by activating cyclin D-CDK4/6-Rb and ERα pathway (2018 · Nature Communications · 被引 74)
• ZFHX3 is indispensable for ERβ to inhibit cell proliferation via MYC downregulation in prostate cancer cells (2019 · Oncogenesis · 被引 57)
• Zfhx3 is essential for progesterone/progesterone receptor signaling to drive ductal side-branching and alveologenesis in mouse mammary glands (2019 · Journal of genetics and genomics/Journal of Genetics and Genomics · 被引 21)
• Creating electrostatic shielding effects through dual-salt strategy to regulate coordination environment of Li⁺ and realize high-performance all-solid-state lithium metal batteries (2025 · Energy storage materials · 被引 18)
• ZFHX3 acts as a tumor suppressor in prostate cancer by targeting FTO-mediated m6A demethylation (2024 · Cell Death Discovery · 被引 13)